Plant derivative kills leukemia cells
Key points
- Parthenolide, a chemical derived from the feverfew plant, destroys acute myeloid leukemia (AML) cells, leaving normal bone marrow cells relatively unscathed.
- Moreover, the compound may get at the root of the disease because it also kills stem cells that give rise AML.
- "This research is a very important step in setting the stage for future development of a new therapy for leukemia," senior author Dr.
- "We have proof that we can kill leukemia stem cells with this type of agent, and that is good news."
Parthenolide, a chemical derived from the feverfew plant, destroys acute myeloid leukemia (AML) cells, leaving normal bone marrow cells relatively unscathed.
Moreover, the compound may get at the root of the disease because it also kills stem cells that give rise AML.
"This research is a very important step in setting the stage for future development of a new therapy for leukemia," senior author Dr. Craig T. Jordan, from the University of Rochester School of Medicine in New York, said in a statement.
"We have proof that we can kill leukemia stem cells with this type of agent, and that is good news."
The findings, which appear in the medical journal Blood, are based on lab dish experiments looking into parthenolide's destructive effects.
The chemical showed a strong ability to trigger the death of human AML cells as well as chronic myelogenous leukemia (CML) cells. In fact, this agent was found to be much more specific to leukemia cells than the standard chemotherapy drug Ara-C.
Further analysis revealed that parthenolide selectively targets stem cell populations.
Thus, the investigators conclude that parthenolide is representative of "a potentially important new class of drugs for leukemia stem cell targeted therapy."
SOURCE: Blood, online February 1, 2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →NewsEngineered cells could help tackle the third most common cancer in Chinese males
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients. The research, published in…
11 March 2015
NewsHeating targeted cancer drugs increases uptake in tumor cells
Manchester scientists have found that gentle heating of targeted nano-sized drug parcels more effectively in deliver them to tumour cells - resulting in an improvement in survival rates. One of the…
12 February 2015
NewsHow tumor-causing cells are recruited in cancers linked to chronic inflammation
Chronic inflammation is directly associated with several types of cancer, yet the reasons as to why this happens at a cellular level remain unclear. Now, an international team of scientists led by researchers at The…
